Maccecchini Maria-Luisa
Insider CIK 1315018 · ANVS President and CEO, Director, 10% owner · LTRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTRN Lantern Pharma Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 21,152 | — | $0 | 21,152 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2025-10-28 | 2025-11-12 | 97,561 | $2.05 | $200.0K | 1,212,020 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2025-06-04 | 2025-06-05 | 46,000 | $3.37 | $155.0K | 1,114,459 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | G Gift | 2024-03-31 | 2024-07-03 | 10,000 | — | $0 | 1,068,459 | SEC↗ |
| ANVS Annovis Bio, Inc. | G Gift | 2024-03-31 | 2024-07-03 | 10,000 | — | $0 | 1,078,459 | SEC↗ |
| ANVS Annovis Bio, Inc. | G Gift | 2024-03-28 | 2024-07-03 | 10,000 | — | $0 | 1,088,459 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-11-20 | 2023-11-21 | 41,186 | $6.07 | $250.0K | 1,098,675 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-11-20 | 2023-11-22 | 40,970 | $6.10 | $249.9K | 1,098,459 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-11-17 | 2024-07-03 | 108,800 | — | $0 | 108,800 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-11-17 | 2024-07-03 | 252,000 | — | $0 | 252,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | G Gift | 2023-04-24 | 2023-04-26 | 3,000 | — | $0 | 1,057,489 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-04-07 | 2023-04-11 | 20,000 | $12.61 | $252.2K | 1,060,489 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise deriv | 2023-02-06 | 2023-02-08 | 52,755 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise | 2023-02-06 | 2023-02-08 | 52,755 | $0.14 | $7.4K | 1,040,489 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-01-18 | 2023-01-20 | 21,312 | — | $0 | 21,312 | SEC↗ |
| LTRN Lantern Pharma Inc. | A Award deriv | 2022-10-20 | 2022-10-24 | 3,200 | — | $0 | 3,200 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-18 | 32,959 | — | $0 | 52,755 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise | 2022-01-14 | 2022-01-18 | 32,959 | $0.14 | $4.6K | 987,734 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 19,894 | — | $0 | 19,894 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 83,400 | — | $0 | 83,400 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2021-12-06 | 2021-12-08 | 112,995 | — | $0 | 112,995 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2021-12-06 | 2021-12-08 | 145,305 | — | $0 | 145,305 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2021-10-11 | 2021-10-13 | 18,000 | $27.61 | $497.0K | 976,775 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2021-07-07 | 2021-07-09 | 41,700 | — | $0 | 41,700 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2020-04-09 | 2020-04-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 11,111 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 1,068,054 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 7,937 | — | $0 | 215,879 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2020-01-31 | 2020-02-05 | 1,600 | $6.00 | $9.6K | 207,942 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 762,896 | — | $0 | 978,775 | SEC↗ |